Gengyi Wu

Gengyi Wu

Auto-generated profile, based on publicly available information

Gengyi Wu

School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology, Tsinghua University, Beijing, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
YLYouxue Lu
Youxue Lu
CLCe Luo
Ce Luo
LHLanxiang Huang
Lanxiang Huang
GWGengyi Wu
Gengyi Wu
LZLihan Zhong
Lihan Zhong
DPDeng Pan
Deng Pan
Tumor-associated macrophages (TAM) display remarkable functional heterogeneity, yet the molecular mechanisms driving their diverse phenotypes remain elusive. Using CRISPR screens in primary macrophages, we identified tumor-derived factors, including lactic acid, prostaglandin E2, and GM-CSF, as key modulators of TAM polarization. These factors interacted cooperatively and antagonistically to shape distinct TAM phenotypes that were highly conserved across human cancers. Mechanistically, lactic acid and PGE2 jointly induced angiogenic gene programs while suppressing GM-CSF–driven MHC-II expression at the chromatin level, creating mutually exclusive distributions of proangiogenic and MHC-II+ TAMs, which were differentially localized to specific spatial niches in the tumor microenvironment. Furthermore, we showed that shifting TAMs to an interferon-responsive phenotype, triggered by Adar inactivation, significantly promoted the infiltration of effector CD8+ T cells through specific receptor–ligand interactions. These findings uncover a conserved mechanism of TAM polarization and offer insights into therapeutic strategies for TAM reprogramming to potentiate cancer immunotherapy.

2 December 2025
Verified
Other
Open access
YLYouxue Lu
Youxue Lu
CLCe Luo
Ce Luo
LHLanxiang Huang
Lanxiang Huang
GWGengyi Wu
Gengyi Wu
LZLihan Zhong
Lihan Zhong
DPDeng Pan
Deng Pan
ScRNA-seq datasets for correlation analysis of macrophages' functional programs with effector signature in T cells, Related to Supplementary Figure S12 and Methods

2 December 2025
Verified
Other
Open access
YLYouxue Lu
Youxue Lu
CLCe Luo
Ce Luo
LHLanxiang Huang
Lanxiang Huang
GWGengyi Wu
Gengyi Wu
LZLihan Zhong
Lihan Zhong
DPDeng Pan
Deng Pan
Inactivation of Adar in myeloid cells rewire TAMs into ISG + phenotype, Related to Figure7.

2 December 2025
Verified
Other
Open access
YLYouxue Lu
Youxue Lu
CLCe Luo
Ce Luo
LHLanxiang Huang
Lanxiang Huang
GWGengyi Wu
Gengyi Wu
LZLihan Zhong
Lihan Zhong
DPDeng Pan
Deng Pan
Correlation of TAM functional program with effector signature in CD8+ T cells in human cancer, Related to Figure 7.

2 December 2025
Verified
Other
Open access
YLYouxue Lu
Youxue Lu
CLCe Luo
Ce Luo
LHLanxiang Huang
Lanxiang Huang
GWGengyi Wu
Gengyi Wu
LZLihan Zhong
Lihan Zhong
DPDeng Pan
Deng Pan
Treatment with tumor-conditioned medium upregulates angiogenic gene expression and suppresses MHC-II and interferon gene expression programs in BMDMs, Related to Figure 1.

2 December 2025
Verified
Other
Open access
YLYouxue Lu
Youxue Lu
CLCe Luo
Ce Luo
LHLanxiang Huang
Lanxiang Huang
GWGengyi Wu
Gengyi Wu
LZLihan Zhong
Lihan Zhong
DPDeng Pan
Deng Pan
The angiogenic and MHC-II gene expression programs are mutually exclusive in human TAMs across a wide range of cancer types, Related to Figure 1.